Cargando…
Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
Background: The aim of the study was to assess soluble ST2 (sST2) concentration and its dynamic changes in the periprocedural period in patients with chronic thromboembolic pulmonary hypertension (CTEPH) treated with balloon pulmonary angioplasty (BPA). Methods: We prospectively analyzed 57 procedur...
Autores principales: | Banaszkiewicz, Marta, Pietrasik, Arkadiusz, Florczyk, Michał, Kędzierski, Piotr, Piłka, Michał, Mańczak, Rafał, Kochman, Janusz, Opolski, Grzegorz, Torbicki, Adam, Kurzyna, Marcin, Darocha, Szymon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830401/ https://www.ncbi.nlm.nih.gov/pubmed/33467121 http://dx.doi.org/10.3390/diagnostics11010133 |
Ejemplares similares
-
Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Piłka, Michał, et al.
Publicado: (2021) -
Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2020) -
Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023) -
Circulating Blood-Based Biomarkers in Pulmonary Hypertension
por: Banaszkiewicz, Marta, et al.
Publicado: (2022) -
Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension
por: Piłka, Michał, et al.
Publicado: (2020)